-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Phathom Pharmaceuticals (PHAT)
-
-
-
-
-
-
-
Phathom Pharmaceuticals Announces Pricing of $130 Million Offering of Common Stock and Pre-Funded Warrants
-
-
-
-
-
-
-
Phathom Pharmaceuticals to Present at the H.C. Wainwright 24th Annual Global Investment Conference
-
21,396 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

